Bright Minds Biosciences (DRUG) Stock Price, Quote, News & History | Benzinga

Bright Minds Biosciences Inc (DRUG) Stock Price, Quote, News & History

DRUGNASDAQ

Trade with Public

Trade with Public

$71.12

0.280.4%

At close: Sep 1, 5:00 PM EST

$72.81

1.972.78%

Pre-Market: 4:10 AM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

-

Close

$71.12

Volume / Avg.

0 / 277.77K

Day Range

- - -

52 Wk Range

38.00 - 123.75

Market Cap

$714.42M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

45

Short Interest

11.87%

Days to Cover

5.42

Recent Bright Minds Biosciences Inc. News

Crude Oil Down 2%; ISM Services PMI Surges In December

Avi Kapoor

Bright Minds Biosciences, Praxis Precision Medicines And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Avi Kapoor

SanDisk To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Wednesday

Avi Kapoor

New Bright Minds Epilepsy Drug Cuts Seizures, Lifts Stock On Tuesday

Bright Minds' stock rose after its epilepsy drug cut seizures in a Phase 2 trial, showed good safety, and improved sleep, setting up plans for larger global studies.

Vandana Singh

Microchip Technology, Alumis, Terrestrial Energy, Bright Minds Biosciences And Other Big Stocks Moving Higher On Tuesday

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-24.67M

Investing Cash Flow (TTM)

-

Financing Cash Flow (TTM)

275.26M

Free Cash Flow (TTM)

-24.67M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

250.59M

Analyst Trends and Forecast

2

Mar

1

Apr

1

May

1

Jun

2

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.2

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$479.37M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

3.15

Earnings Yield % (TTM)

-2.87%

Earnings Yield % (FWD)

-8.16%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$22.64

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$104.77K

Total Cash

$307.83M

Debt to Equity

0.00

Issuance of Debt (TTM)

-$104.77K

Repayment of Debt (TTM)

-$104.77K

Key Statistics

Open

-

Close

$71.12

Volume / Avg.

0 / 277.77K

Day Range

- - -

52 Wk Range

38.00 - 123.75

Market Cap

$714.42M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

45

Short Interest

11.87%

Days to Cover

5.42

About

Sector

Health Care

Industry

Biotechnology

Bright Minds Biosciences Inc is focused on developing novel, transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Bright Minds Biosciences (DRUG) stock?

A

You can purchase shares of Bright Minds Biosciences (NASDAQ:DRUG) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Bright Minds Biosciences (DRUG) competitors?

A

Other companies in Bright Minds Biosciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Bright Minds Biosciences (DRUG) stock?

A

Bright Minds Biosciences has a consensus price target of $128.14.

Q

What is the current price for Bright Minds Biosciences (DRUG)?

A

The stock price for Bright Minds Biosciences (NASDAQ: DRUG) is $72.81 last updated August 28, 2026 at 4:00 PM EDT.

Q

Does Bright Minds Biosciences (DRUG) pay a dividend?

A

There are no upcoming dividends for Bright Minds Biosciences.

Q

When is Bright Minds Biosciences (NASDAQ:DRUG) reporting earnings?

A

Bright Minds Biosciences does not have any upcoming earnings scheduled.

Q

Is Bright Minds Biosciences (DRUG) going to split?

A

There is no upcoming split for Bright Minds Biosciences.

Q

What sector and industry does Bright Minds Biosciences (DRUG) operate in?

A

Bright Minds Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.